Literature DB >> 11969366

EG-VEGF and the concept of tissue-specific angiogenic growth factors.

Jennifer LeCouter1, Napoleone Ferrara.   

Abstract

The endothelium of the vascular beds is extremely diverse and exquisitely distinct with respect to the specific tissue compartment served by the vessels. The molecular identity and function of the instructive signals that tailor the tissue-specific endothelial phenotype have been largely undefined. Presumably, a complex, integrated network of signals derived from the tissue parenchyma and/or stromal compartments is responsible. Recently, we identified a novel angiogenic mitogen, endocrine-gland-derived vascular endothelial growth factor, EG-VEGF, with a selective activity and very distinct expression pattern. Human EG-VEGF is expressed by steroid producing cells in the adrenal gland, placenta, testis and ovary, and is a mitogen for endothelial cells derived from these microvascular beds. EG-VEGF may represent the first of a novel class of tissue-specific angiogenic factors that function to regulate and fine-tune endothelial cell growth, structural and functional properties. The identification of other selective angiogenic molecules will allow insight into exciting, basic developmental issues and increase our armamentarium of factors for therapeutic angiogenic and anti-angiogenic strategies. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11969366     DOI: 10.1006/scdb.2001.0284

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  3 in total

1.  Vascular endothelial growth factor and kinase domain region receptor are involved in both seminiferous cord formation and vascular development during testis morphogenesis in the rat.

Authors:  Rebecca C Bott; Ryann M McFee; Debra T Clopton; Candice Toombs; Andrea S Cupp
Journal:  Biol Reprod       Date:  2006-05-03       Impact factor: 4.285

Review 2.  The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis.

Authors:  Nadia Alfaidy; Pascale Hoffmann; Houssine Boufettal; Naima Samouh; Touria Aboussaouira; Mohamed Benharouga; Jean-Jacques Feige; Sophie Brouillet
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

Review 3.  Prokineticin Is a New Linker between Obesity and Cardiovascular Diseases.

Authors:  Canan G Nebigil
Journal:  Front Cardiovasc Med       Date:  2017-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.